Author Summary
CAV1 is a potential marker for distinguishing benign prostatic hyperplasia and prostate cancer patients
Prostate cancer (PCa) is a highly frequent malignancy in men worldwide. Early detection methods are digital rectal examination and elevated prostate-specific antigen (PSA) levels which are indications for prostate biopsy. PSA is not cancer-specific and […]
